Cargando…

Introducing pro and con discussions in ESMO Open—Cancer Horizons

Detalles Bibliográficos
Autores principales:	Zielinski, C., Preusser, M., Berghoff, A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271473/ https://www.ncbi.nlm.nih.gov/pubmed/35798470 http://dx.doi.org/10.1016/j.esmoop.2022.100467

Ejemplares similares

CDK4/6 inhibition in low burden and extensive metastatic breast cancer: summary of an ESMO Open—Cancer Horizons pro and con discussion
por: Awada, Ahmad, et al.
Publicado: (2019)

New emerging targets in cancer immunotherapy beyond CTLA-4, PD-1 and PD-L1: Introducing an “ESMO Open – Cancer Horizons” Series
por: Lambertini, Matteo, et al.
Publicado: (2019)

ESMO Open—Cancer Horizons and the future of oncology
por: Zielinski, Christoph C
Publicado: (2016)

CSCO joins ESMO Open—Cancer Horizons
por: Zielinski, Christoph C, et al.
Publicado: (2016)

AIOM chooses ESMO Open—Cancer Horizons as its official journal: a warm welcome from ESMO Open
por: Zielinski, Christoph C, et al.
Publicado: (2016)

One year of ESMO Open: Cancer Horizons—where are we going from here?
por: Zielinski, Christoph
Publicado: (2017)

Announcing the ESMO Open special issue on upcoming molecular targets for cancer treatment
por: Morgan, Gilberto, et al.
Publicado: (2020)

Introducing a new ESMO Open article series: how I treat side effects of immunotherapy
por: Preusser, Matthias
Publicado: (2019)

First-line PARP inhibitors in ovarian cancer: summary of an ESMO Open - Cancer Horizons round-table discussion
por: Banerjee, Susana, et al.
Publicado: (2020)

Managing toxicities with asparaginase-based therapies in adult ALL: summary of an ESMO Open–Cancer Horizons roundtable discussion
por: Burke, Patrick W, et al.
Publicado: (2020)

ESMO Open welcomes the association with the Japanese Society of Medical Oncology (JSMO)
por: Ohe, Yuichiro, et al.
Publicado: (2017)

Challenge of implementing clinical practice guidelines. Getting ESMO’s guidelines even closer to the bedside: introducing the ESMO Practising Oncologists’ checklists and knowledge and practice questions
por: Rauh, Stefan, et al.
Publicado: (2018)

ESMO Clinical Practice Guidelines: adapting and adopting new approaches for development, implementation and audit
por: Pentheroudakis, G., et al.
Publicado: (2022)

Nachwuchsförderung durch die European Society for Medical Oncology (ESMO): Erfahrungen aus dem ESMO Young Oncologist Committee (YOC)
por: Oing, Christoph, et al.
Publicado: (2020)

ESMO Open: news in breast cancer 2019
por: Lambertini, Matteo
Publicado: (2020)

ESMO pays tribute to Professor José Baselga
por: Peters, S., et al.
Publicado: (2021)

ESMO and WHO: 14 years of working in partnership on cancer control
por: Ullrich, Andreas, et al.
Publicado: (2016)

ESMO Copenhagen 2016: a lung cancer ‘grand cru’
por: Douillard, Jean-Yves
Publicado: (2017)

WHO-ESMO collaboration in cancer control: policies into action to save lives
por: Mikkelsen, B., et al.
Publicado: (2022)

Introducing Open Biology
por: Glover, David, et al.
Publicado: (2011)

Introducing RMD Open
por: Cutolo, Maurizio, et al.
Publicado: (2015)

Rituximab biosimilars open new horizons in immunotherapy
por: Jaeger, Ulrich
Publicado: (2017)

The ESMO Call to Action on COVID-19 vaccinations and patients with cancer: Vaccinate. Monitor. Educate
por: Garassino, M.C., et al.
Publicado: (2021)

Cardiothoracic Imaging in China: Opening Up New Horizons
por: Zhang, Long Jiang, et al.
Publicado: (2022)

Introducing JBJS Open Access
por: Swiontkowski, Marc, et al.
Publicado: (2016)

Applying the ESMO-Magnitude of Clinical Benefit Scale in real life
por: Ciardiello, Fortunato, et al.
Publicado: (2016)

Detailed statistical assessment of the characteristics of the ESMO Magnitude of Clinical Benefit Scale (ESMO-MCBS) threshold rules
por: Dafni, Urania, et al.
Publicado: (2017)

Cancer immune cycle: a video introduction to the interaction between cancer and the immune system
por: Preusser, Matthias, et al.
Publicado: (2016)

ESMO Open special series on new emerging targets in cancer immunotherapy
por: Lambertini, Matteo
Publicado: (2020)

The ESMO/ASCO Global Curriculum and the evolution of medical oncology training in Europe
por: Pavlidis, Nicholas, et al.
Publicado: (2016)

EHA Endorsement of ESMO Clinical Practice Guidelines for Marginal Zone Lymphomas
por: Ladetto, Marco, et al.
Publicado: (2020)

Introducing ‘Open Questions’ article type
por: Cyert, Martha S.
Publicado: (2020)

CECOG educational illustrations: the blood–brain barrier and its relevance for targeted cancer therapies and immuno-oncology
por: Preusser, Matthias, et al.
Publicado: (2017)

ESMO/ASCO recommendations for a Global Curriculum (GC) in medical oncology—edition 2016
por: Dittrich, C., et al.
Publicado: (2016)

Open New Horizons With the International Journal of Heart Failure for Global Connection
por: Park, Seong-Mi
Publicado: (2022)

The ESMO position paper on biosimilars in oncology: enhancing the provision of accurate education and information
por: Schiestl, Martin, et al.
Publicado: (2017)

Expanding Horizons in Cancer Imaging
por: Ramaiya, Nikhil H.
Publicado: (2017)

Immune checkpoint inhibitor treatment in patients with oncogene-addicted non-small cell lung cancer (NSCLC): summary of a multidisciplinary round-table discussion
por: Berghoff, Anna S., et al.
Publicado: (2019)

The good physician and the great physician: why a physician should consider the ESMO guidelines on the management of cancer cachexia?
por: Laviano, A.
Publicado: (2022)

HORIZON I: Is there a future for oral anti-angiogenics on the horizon of colorectal cancer therapy?
por: Hochster, H S
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_70agrfvo4r4c6niva7q0r4m584